Inclusive of all taxes
Theophylline Prolonged Release Tablets 400 mg are specially formulated pharmaceutical tablets designed for the effective management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These tablets provide a controlled, sustained release of theophylline, ensuring extended therapeutic effects and stable plasma drug concentration for enhanced patient compliance and symptom control. Manufactured under stringent WHO-GMP standards by IndiGlobal Exports, this product ensures high purity, consistent dosage, and compliance with international pharmacopeial standards (IP/USP). The tablets come in export-quality blister or strip packaging, facilitating secure distribution and maintaining drug stability. It is optimal for hospitals, pharmacies, and healthcare institutions requiring reliable and quality-assured prolonged release theophylline medication to manage respiratory ailments effectively. The formulation is tailored to meet the needs of regulated and semi-regulated pharmaceutical markets globally, offering safe and efficacious treatment with minimized risk of dose fluctuations or adverse effects.
Key Features
| Features | Description |
|---|---|
| Dosage Strength | 400 mg per tablet |
| Formulation Type | Prolonged Release Tablet |
| Indication | Management of respiratory conditions including asthma and COPD |
| Manufacturing Standards | WHO-GMP certified facilities |
| Packaging | Export-grade blister or strip packs |
| Compliance | Meets IP/USP pharmacopeial standards |
| Therapeutic Performance | Consistent plasma concentration with controlled release |
| Market Suitability | Suitable for international pharmaceutical markets |
| Manufacturer | IndiGlobal Exports |
| Shelf Life | As per regulatory standards |
| Attributes | Description |
|---|---|
| Active Ingredient | Theophylline |
| Dosage Form | Tablet |
| Strength | 400 mg |
| Release Type | Prolonged/Extended Release |
| Therapeutic Class | Respiratory / Bronchodilator |
| Packaging Type | Blister or strip packs |
| Compliance Standard | WHO-GMP, IP/USP |
| Intended Use | Respiratory therapy for management of asthma and COPD |
| Storage | Store in a cool, dry place away from direct sunlight |
| Shelf Life | As per regulatory norms |
| Manufacturer | IndiGlobal Exports |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
The prolonged release formulation ensures a steady release of theophylline into the bloodstream, maintaining therapeutic drug levels over an extended period which helps in better symptom control and reduces the frequency of dosing compared to immediate release formulations.
Yes, Theophylline Prolonged Release Tablets 400 mg are manufactured in WHO-GMP compliant facilities and meet IP/USP pharmacopoeial standards, making them suitable for regulated and semi-regulated international pharmaceutical markets.
The tablets are available in export-quality blister or strip packs that ensure product stability, ease of handling, and compliance with international shipping and storage requirements, making them ideal for bulk institutional procurement.
No, these prolonged release tablets are designed to maintain constant plasma levels of theophylline and should not be interchanged directly with immediate release products without medical supervision, as dosing frequency and blood levels differ.
Each batch undergoes rigorous quality control testing adhering to WHO-GMP and pharmacopeial standards (IP/USP), ensuring consistent dosage, purity, and therapeutic efficacy.
Brand: indiglobal exports
Country Of Origin: India
Theophylline Prolonged Release Tablets 400 mg is a pharmaceutical product indicated for respiratory treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Theophylline Prolonged Release Tablets 400 mg is developed for the effective management of respiratory conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with respiratory indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
